Bhang products will soon be available to Florida’s more than 150,000 medical cannabis patients, pending regulatory approval by the Office of Medical Marijuana Use
MIAMI, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Florida’s medical cannabis patients will soon be able to access some of the world’s most awarded cannabis products thanks to a partnership between Bhang and Trulieve.
“We’re proud to partner with the leading medical cannabis company in the state of Florida,” commented Scott Van Rixel, Founder & CEO of Bhang. “Trulieve is an outstanding cannabis company with extensive knowledge, resources, and passion in everything they do and we believe that this partnership will be a great fit for Bhang in Florida.”
The agreement will bring Bhang’s extensive line of edible cannabis-infused products to Trulieve, Florida’s preeminent medical cannabis provider. Once the products receive approval from the Florida Department of Health’s Office of Medical Marijuana Use, Bhang will be available exclusively at Trulieve. Presently, there can be no assurance as to the timing and scope of such regulatory approval, when and if it is obtained.
“We continue to look for partnerships that will benefit our patients and continue to provide relief in a safe, dependable manner. As an international, award-winning brand and customer favorite, Bhang’s flavorful, consistent, and reliable products will truly enhance what we can offer to our patients,” said Kim Rivers, CEO of Trulieve.
This agreement is part of Bhang’s continued worldwide expansion. The company’s popular products are currently available in California, New Mexico, and Michigan, with Illinois, Canada, and Germany in the process of coming online. Bhang expects to expand into Puerto Rico and more international hubs like Austria, Liechtenstein, and Switzerland through 2019.
According to a report from BDS Analytics and The Arcview Group, Florida’s medical cannabis market is expected to grow rapidly and exceed $1 billion by 2020. With a population of 21 million, 19 percent of whom are seniors, Florida is on track to have hundreds of thousands of medical marijuana patients. The burgeoning system currently has more than 150,000 registered patients and 1,650 registered physicians, with those numbers expected to almost triple by 2020.
Leaders in the cannabis industry, the Bhang team produces the most-awarded line of cannabis chocolate bars on the planet, as well as a premium collection of vapes, gums and mouth sprays. Developed by Scott Van Rixel, a professional chef and Master Chocolatier with 25+ years of gourmet chocolate experience, the artisan chocolate bars pair the best in sustainably-source, free-trade cacao with adventurous flavors and high-quality, lab-tested, CO2-extracted cannabis oil. Patients across the country report they are thrilled with Bhang’s consistency, reliability and premium quality. If you are 21+, please follow @bhang.chocolate on Instagram, @bhangchocolates on Facebook and @bhangchocolate on Twitter.
Brand Wagon Agency
Trulieve is a vertically-integrated ‘seed-to-sale’ company and is the first and largest fully-licensed medical marijuana company in the state of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to their medical marijuana treatment centers throughout the state of Florida, as well as directly to patients via home delivery.
As a vertically-integrated company with a patient-first mantra, Trulieve has developed a suite of products with over 80 SKUs, including flower cartridges for vaporizing, concentrates, topicals, capsules, tinctures, and vaporizer cartridges.
Headquartered in Quincy, Florida, Trulieve is focused on being the brand leader for quality medical cannabis products and service in Florida and beyond. Trulieve employs over 800 people and is committed to providing patients a consistent and welcoming retail experience across their stores. For more information, please visit: www.trulieve.com.
Regarding Forward-Looking Information
This news release contains statements that constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects," "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur.
Forward-looking statements in this document include, but are not limited to, statements regarding the anticipated benefits of the relationship between Bhang and Trulieve, the anticipated regulatory approval and ultimate sale of Bhang products in Trulieve dispensaries, and the anticipated growth of the Florida medical cannabis market generally. By their nature, forward-looking statements are based on the opinions and estimates of management at the date the information is made, and is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. Neither Bhang nor Trulieve is under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.